Latest News

08 October 2019
News

We will be attending the SCI New Synthetic Methods II Symposium being held in London, Belgrave Square on 10th October. With an excellent line up of speakers we are looking forward to a great day of talks and networking opportunities. Come and talk to our Business Development Manager Dr Aamar Khan.


08 August 2019
News

We have expanded our purification capabilities with the addition of a new CombiFlash system. Automated purification equipment allows our chemists to focus their time on more challenging chemistry in the lab.


23 July 2019
News

Dr Aamar Khan has joined Apex Molecular as a Business Development Manager with a focus on new business growth. Aamar has a PhD in Chemistry from Manchester Metropolitan University and previous business development experience in a European CMO/CRO. Aamar will focus on identifying and growing Apex Molecular’s new business customers in our standard and high […]


14 March 2019
Insights

The world-wide number of pre-clinical drugs under development over 2017-2018 increased from 7493 to 8040, a whopping 7.3% (1). The largest class of these drugs, synthetic chemicals, increased from 7855 to 7992 throughout the same period. The second largest, antibody drugs, similarly showed considerable growth from 1687 to 1809 (7.2%). Overall the largest therapeutic class, […]


11 March 2019
News

As the company continues to expand we have purchased additional laboratory equipment to enable us to continue to efficiently deliver for our customers. Recently we have installed an analytical LCMS,  preparative HPLC system (pictured below) and a freeze dryer. This additional equipment has increased productivity on our medicinal chemistry projects which is great news for […]


01 March 2019
News

Apex Molecular appointed Mark Warburton as a Non-executive Director on 1 December 2018. Mark’s experience as a corporate finance/banking lawyer and as COO of Cyprotex Discovery will add significantly to the corporate governance and commercial activities of the Company in the coming years of the Company’s growth and development.


Make an enquiry

Send us your details, and one of
our expert team will be in touch